ADAMTSL2 and metabolic dysfunction-associated steatotic liver disease: ADAMTSL2 has been linked to fibrosis in various contexts, including liver fibrosis in nonalcoholic fatty liver disease, cardiac fibrosis, and fibrosis in several organs in Musladin-Lueke syndrome (18, 29, 38, 39).